InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,709.54
(
0.01%
)
US TECH 100
19,324.00
(
0.38%
)
Dow Jones
42,196.52
(
0.09%
)
Brent Oil
74.81
(
0.25%
)
Bitcoin
61,117.85
(
0.81%
)
Post# of 2347474
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Itza-Sherbet

Send PM Follow Ignore
Followers 18
Posts 1044
Boards Moderated 1
Alias Born 07/17/2013

Itza-Sherbet

Re: None

Monday, 07/22/2013 7:45:54 PM

Monday, July 22, 2013 7:45:54 PM

Post# of 2347474
ABIO. Institutional investors doing steady accumulation here. They are planning to initiate GENETIC-AF, a Phase 2B/3 clinical study of Gencaro in AF patients with heart failure and reduced left ventricular ejection fraction ("HFREF"). Huge market potential, this one about to move.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up